Hedge Fund - Cormorant Asset Management
Bridgebio Pharma Inc. (BBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $135,004,506 | 6.44% | 3,344,179 | $30.03 |
| 2 | 2023 - Q3 (2023-09-30) | $122,950,916 | 7.17% | 4,662,530 | $28.38 |
| 3 | 2023 - Q2 (2023-06-30) | $71,709,879 | 4.01% | 4,169,179 | $15.05 |
| 4 | 2023 - Q1 (2023-03-31) | $75,562 | 4.97% | 4,557,414 | $11.66 |
| 5 | 2022 - Q4 (2022-12-31) | $10,433 | 0.69% | 1,369,179 | $9.57 |
| 6 | 2022 - Q3 (2022-09-30) | $14,604,000 | 1.02% | 1,469,179 | $10.39 |
| 7 | 2022 - Q2 (2022-06-30) | $13,340,000 | 1% | 1,469,179 | $8.36 |
| 8 | 2022 - Q1 (2022-03-31) | $15,924,000 | 1.22% | 1,568,909 | $10.26 |
| 9 | 2021 - Q4 (2021-12-31) | $27,837,000 | 1.65% | 1,668,909 | $42.31 |
| 10 | 2021 - Q3 (2021-09-30) | $82,909,000 | 3.36% | 1,768,909 | $53.60 |
| 11 | 2021 - Q2 (2021-06-30) | $114,665,000 | 3.89% | 1,880,980 | $57.11 |
| 12 | 2021 - Q1 (2021-03-31) | $133,605,000 | 2.97% | 2,168,909 | $65.42 |
| 13 | 2020 - Q4 (2020-12-31) | $161,118,000 | 3.83% | 2,265,762 | $48.24 |
| 14 | 2020 - Q3 (2020-09-30) | $85,011,000 | 3.26% | 2,265,762 | $31.46 |
| 15 | 2020 - Q2 (2020-06-30) | $84,485,000 | 3.22% | 2,590,762 | $30.46 |
| 16 | 2020 - Q1 (2020-03-31) | $85,550,000 | 3.97% | 2,950,000 | $31.01 |
| 17 | 2019 - Q4 (2019-12-31) | $88,076,000 | 3.51% | 2,512,865 | $27.72 |
| 18 | 2019 - Q3 (2019-09-30) | $56,199,000 | 3.42% | 2,617,566 | $27.66 |
| 19 | 2019 - Q2 (2019-06-30) | $75,000,000 | 4.3% | 2,780,885 | $27.26 |
The displayed share prices are average quarterly stock market prices.